Back
Cartesian Therapeutics, Inc. Stock Predictions
Get Paid In ANY Crypto Market
Learn the crash-proof system. Watch the free training.
Sell
44
RNAC
Cartesian Therapeutics, Inc.
Last Price:
$7.79
Seasonality Move:
-7.88%
7 Day Trial
ALL ACCESS PASS
$
7
Where Smart Money Buys Crypto (Hint: Not Coinbase)
Access Native Markets before the next 100x asset goes mainstream. Watch free training.Cartesian Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, Cartesian Therapeutics, Inc. has on average historically fallen by 23.1% based on the past 9 years of stock performance.
-
Cartesian Therapeutics, Inc. has fallen lower in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
-
Is Cartesian Therapeutics, Inc. Stock Undervalued?The current Cartesian Therapeutics, Inc. [RNAC] share price is $7.76. The Score for RNAC is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
RNAC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
Will Cartesian Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, Cartesian Therapeutics, Inc. has on average historically fallen by 23.1% based on the past 9 years of stock performance.
Cartesian Therapeutics, Inc. Stock Rating
Sell
44
Cartesian Therapeutics, Inc. (RNAC)
is a Sell
Is Cartesian Therapeutics, Inc. overpriced?
-
Cartesian Therapeutics, Inc. has fallen lower in 6 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 66.67%
Cartesian Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
cartesiantherapeutics.com
52-Week Data
52-Week High:
20.12
52-Week Low:
5.98
Prediction Charts
Market Cap:
201.8M
Price in USD:
7.76
Volume:
181.4K
Beta:
0.86
Technical Analysis
SMA50:
7.45
SMA100:
8.73
SMA200:
10.07
52-Wk Change:
-54.78%
Stock Predictions
-
Is Cartesian Therapeutics, Inc. stock public?Yes, Cartesian Therapeutics, Inc. is a publicly traded company.
-
What is the Cartesian Therapeutics, Inc. stock quote today?The Cartesian Therapeutics, Inc. stock price is 7.76 USD today.
-
How to buy Cartesian Therapeutics, Inc. stock online?You can buy Cartesian Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-17 | 8.28 | 7.43 | 8.36 | 7.38 |
| Dec-18 | 7.50 | 7.36 | 7.75 | 7.21 |
| Dec-19 | 7.43 | 7.22 | 7.60 | 7.13 |
| Dec-22 | 7.23 | 6.72 | 7.25 | 6.69 |
| Dec-23 | 6.70 | 6.43 | 6.84 | 6.40 |
| Dec-24 | 6.41 | 6.76 | 6.83 | 6.41 |
| Dec-26 | 6.70 | 6.68 | 6.88 | 6.48 |
| Dec-29 | 6.63 | 6.47 | 6.74 | 6.43 |
| Dec-30 | 6.45 | 6.94 | 7.00 | 6.40 |
| Dec-31 | 6.93 | 7.21 | 7.26 | 6.88 |
| Jan-2 | 7.29 | 6.76 | 7.31 | 6.48 |
| Jan-5 | 6.76 | 6.91 | 6.95 | 6.62 |
| Jan-6 | 6.83 | 7.04 | 7.05 | 6.71 |
| Jan-7 | 7.11 | 7.76 | 7.90 | 7.11 |
Cartesian Therapeutics, Inc. Earnings
Cartesian Therapeutics, Inc. Earnings Report: Per Share Cartesian Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
Cartesian Therapeutics, Inc. Forecast Revenue Growth
Cartesian Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for Cartesian Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.65 per share, and an increase next year of $0.22 per share.
* Cartesian Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.